Literature DB >> 34597860

Novel pathogenic variants in an Indian cohort with epidermolysis bullosa: Expanding the genotypic spectrum.

Mayank Nilay1, Deepti Saxena2, Kausik Mandal1, Amita Moirangthem1, Shubha R Phadke1.   

Abstract

BACKGROUND: Epidermolysis bullosa (EB) is a genodermatosis characterized by skin fragility and blisters with variable severity. Patients with Dystrophic EB (DEB) or Junctional EB (JEB) mainly present to clinic due to greater functional impairment. Pathogenic sequence variations in COL7A1 are implicated in DEB.
OBJECTIVE: We have tried to decipher the molecular spectrum and genotype phenotype correlation of 21 Indian patients with EB.
METHODS: Next generation sequencing (NGS) was performed to determine the pathogenic variants. Sanger sequencing was also done for validation of the variants in eleven individuals.
RESULTS: Pathogenic variants were detected in 20 individuals (diagnostic yield of 95%). Majority of them (90%) had sequence variation in COL7A1 while two had pathogenic variants in ITGB4 and KRT14 respectively. Out of the 18 patients confirmed to have DEB, 3 had Dominant DEB (DDEB) whereas 15 patients had Recessive DEB (RDEB). Amongst 23 sequence variations identified, 12 were found to be novel (3 were missense, 5 were premature termination codon variants while 4 were splice-site changes).
CONCLUSION: Genotype phenotype correlation was noted with milder manifestations in those with dominant inheritance types. Exact molecular diagnosis can be ascertained by NGS in majority of cases.
Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  COL7A1; Dystrophic epidermolysis bullosa; Genodermatosis; Next generation sequencing; Novel; Pathogenic variant

Mesh:

Year:  2021        PMID: 34597860     DOI: 10.1016/j.ejmg.2021.104345

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  1 in total

1.  Availability of mRNA Obtained from Peripheral Blood Mononuclear Cells for Testing Mutation Consequences in Dystrophic Epidermolysis Bullosa.

Authors:  Eijiro Akasaka; Hajime Nakano; Daisuke Sawamura
Journal:  Int J Mol Sci       Date:  2021-12-13       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.